NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ACTO

ACTO

Private
TorontoHealthcare & Life Scienceshttps://acto.com/

Last Round

Corporate Funding

Sep 12, 2024

Total Funding Raised

$45.33M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ACTO is a life sciences technology company that provides an AI-powered Intelligent Field Excellence platform to enhance the performance of field representatives through training, coaching, and content management.

Sector

Healthcare & Life Sciences

Verticals

Sales Enablement, Vertical SaaS, NLP & Conversational AI, Workflow Automation, Customer Experience

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

life sciences sales enablementpharma sales trainingAI field simulationAI agentsworkflow automationmedical science liaison trainingcommercial excellence platformvertical SaaSAI copilotsales coaching softwarepharma techenterprise AI agentsVeeva integrationsales readinessSaaS marketplace

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ACTO Comparables

Compare ACTO with similar companies based on industry and business-model similarity.

ACTO comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SmartWinnr
83%
Quantified
79%
Allego
78%

ACTO Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingSep 12, 2024
SeedMar 15, 2024
Series BJul 7, 2022
Series AAug 27, 2020

Key People

Founding team and executive leadership

Ray Newal

Strategic Advisor To CEO

Executive Team

Kumar Erramilli

Chief Technology Officer

Executive Team

Jenny Yeung

Chief Financial Officer

Executive Team

ACTO Investors

Notable investors and investment history

ACTO investors
InvestorRounds
Graphite VenturesCorporate Funding
Maple Leaf AngelsSeed
Panache VenturesCorporate Funding, Series A, Seed, Series B
MaRS Discovery DistrictSeries A, Series B
Questa CapitalCorporate Funding, Series B
Salesforce VenturesSeries A, Series B
Innovation Grade VenturesCorporate Funding, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 13, 2026

    Launched SuperAgents, an AI innovation for Life Sciences professionals.

  • Mar 18, 2026

    Launched AI agents for accelerated Field Excellence in Life Sciences.

ACTO Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ACTO Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ACTO's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range112
Year Founded2014
Last FundingSep 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.